Minutes of the Lambeth and Southwark Joint Prescribing Committee (JPC) meeting pm, Wednesday 9 September 2013 Room 407, 1 Lower Marsh
|
|
- Caitlin Doyle
- 5 years ago
- Views:
Transcription
1 Minutes of the Lambeth and Southwark Joint Prescribing Committee (JPC) meeting pm, Wednesday 9 September 2013 Room 407, 1 Lower Marsh Present: Dr Di Aitken Catherine Otty Sian Howell Sadru Kheraj Iris Javaid Rimal Patel Liz Williams Tase Oputu Vanessa Burgess Anna Jenkins Anna Hodgkinson Devika Sennik Helen Magnusen Baker Helen Williams Jenny Sivaganam Georgina Fihosy Shena Chauhan Kath McPherson In Attendance: Mike Salter Apologies: Gaurang Purohit Dilip Patel GP, Chair (Lambeth CCG) GP, Southwark CCG and LMC Representative, Lambeth GP, CCG Board Medicines Management Lead, Southwark CCG GP, CCG Board Medicines Management Lead (Lambeth CCG) Practice Nurse (Lambeth CCG) Community Pharmacist GP (Lambeth CCG) Formulary Pharmacist, KCH Chief Pharmacist/AD Medicines Management, Lambeth CCG Chief Pharmacist, Southwark CCG Senior Prescribing Advisor, Lambeth CCG Senior Pharmaceutical Advisor, Southwark CCG Senior Pharmaceutical Advisor, Southwark CCG Consultant Pharmacist CVD, Lambeth & Southwark CCGs Prescribing Advisor, Lambeth CCG Senior Primary Care Pharmacist, Southwark CCG Prescribing Advisor, Southwark CCG Medicines Management Intelligence, Lambeth CCG (Minutes) Chief Pharmacist, NHS Lewisham CCG Formulary Pharmacist, GSTT Community Pharmacist, LPC 1. Introduction and welcome DA welcomed members to the meeting. 2. Minutes July 2013 and Declaration of Interests/Conflicts The minutes were accepted as an accurate record subject to deleting LPC rep from RP s role. DA asked for any declarations of interest for the meeting agenda. Page 1 of 5
2 3. Matters Arising i. Guideline on managing ED in severe distress HB presented the checklist which could not be ed in advance due to copyright restrictions. Feedback on the guideline has been received from Dr Popelyuk as follows: Patients may be identified as having organic causes for ED but can also have psychological distress therefore should not be excluded from assessment. It was agreed that the table on page 2 would be deleted. Depression to be replaced by Distress on page 3 scoring table. ** It is important to remember that severity of sexual problems does not always correlate well with CORE 10, so the decision about whether to prescribe PDE-5 should be based on the overall clinical presentation and not on CORE -10 alone. - to be moved to above the scoring table. A score of is highlighted as being outside of NHS prescribing. Dr Hopkirk does not agree and states that prescribing of PD-5s should be considered based on clinical appearance e.g. if the patient appears distressed then PD-5s on FP10 should be considered. The committee agreed this should be worded to suggest rather than recommend. Dr Popelyuk recommended that patients with severe distress should receive an immediate referral to SLAM. JPC felt this would generate multiple referrals and the guideline should be amended to assess mental health status and to refer as appropriate. This also applied to increased despair/suicide risk. The committee questioned why point 5 of the prescribing notes referred to trying 2 PD-5s rather than 3 before referring as failing to respond. HB advised that clinical experts had advised that trying 3 PD-5s increases psychological morbidity. NICE guidance agrees with this. JPC also queried how long a patient should remain on PD-5s and HB responded that it is difficult to have a blanket rule as it depends on individual response. Caution should be taken not to stop treatment before the patient is ready. Counselling should be available to manage expectations. The guideline states there will be no prescribing of tadalafil in primary care. AH felt this was unwise as there may be occasions when it is unavoidable. To be amended to there should not normally be prescribing of tadalafil in primary care. LW suggested the checklist could be added to EMIS web. ACTION: HB to amend as agreed then circulate for review/chair s action and to investigate adding the checklist to EMIS. (Post meeting note: HB has followed up adding to EMIS web with Ryszard Stepaniuk. In his opinion this cannot be done as any form of recreating the check list will be seen as copyright infringement). i. Lambeth & Southwark SOP for Rescue Pack assessment Guideline to facilitate assessment of patients for issue of rescue packs. Patients who are issued with 2 or more in a 12-month period will need to be referred to the specialist. Approved. ii. Southwark COPD Self-Management plan It was noted that currently Lambeth and Southwark are using different versions of the COPD Action plan. Approved ACTION: AH to forward action plan to HB iii. Lambeth and Southwark management of COPD Turbohalers which are the only licensed inhaler are not suitable for COPD patients with a low respiratory rate so local expert opinion recommends prescribing mdi/spacer. VB noted that pharma companies claim to have data that supports use of turbohalers in these patients. JPC discussed the Page 2 of 5
3 use of incheck devices to assess respiratory rate but it was felt this was too much of a leap for primary care. VB cautioned against the principle of including an unlicensed preparation while not including a licensed one. This could be open to challenge. There was some discussion around prescribing dry powder preps but HB added that there is good evidence that maintaining patients on the same type of device has better outcomes. Do not initiate ICS should be in bold caps and stop smoking advice and pulmonary rehabilitation should be listed as steps before referral to secondary care. ACTION: HB to amend and recirculate. 4. GSTT Switch to Dalteparin JPC discussed the unilateral switch from enoxaparin to dalteparin proposed by GSTT. The discussion highlighted the following key areas of concern: The decision to use only one LMWH across all local institutions was taken many years ago to minimise risk, and primary care prescribing for some indications was agreed on the basis of standardisation on one LMWH. A switch to dalteparin at GSTT will undermine this principle and will inevitably increase risk in the system, particularly for primary care where two agents would be in use. The committee also discussed that primary care prescribing of LMWH is not undertaken in most areas across England as this therapy is seen as specialist. The CCGs recognised the potential cost savings from a switch are significant and GSTT. Although, the modelling process used by GSTT has not been made available for scrutiny and the cost modelling undertaken at KCH does not support the same potential for savings. Safe prescribing of Dalteparin in the community. The nomenclature of dalteparin on GP systems significantly increases the risk of prescribing errors. EMIS buys its drug dictionary externally, and the supplier will need to be contacted to see if the drug dictionary can be amended, we do not know if this can be done in a timely manner. There is a cost associated with stocking multiple LMWHS for community pharmacies, particularly in view of the numerous strengths available. If community pharmacies are unwilling to stock both enoxaparin and dalteparin, there may be delays in supply for individual patients There is a lack of clarity over the indications for LMWH prescribing which are currently being transferred to the GP for community prescribing of LMWHs discussion and agreement regarding this is needed. It is understood that a revised pricing structure for Enoxaparin may be proposed by Sanofi Aventis. The committee would recommend: Awaiting an outcome of the change in enoxaparin price - currently with the CMU. Ideally, maintaining the status quo with only one LMWH in the locality; but if GSTFT wish to go ahead with a unilateral switch, that prescribing of all LMWH remain with GSTFT including continuation of medium to long term therapy from the date of the switch. This supply process must be designed to minimise the risks and costs to primary care ie through a repeat dispensing process, rather than incurring additional tariff costs. This process needs to be agreed with the CCGs before implementation ACTION: HW to draft response to GSTT, follow up with JFC and to update on pricing outcome for enoxaparin 5. Bisphosphonate Pathway The pathway has been developed by the MSK group for the use of IV Denosumab. HB informed JPC that she has fed back the following comments which are not yet reflected: P6 of pathway- Clarity required on use in men with a creatinine level under 35mls More cost effective to use denosumab rather than zolendronic acid in the community NICE guidance is that prescribing to be kept in secondary care for 1-year in patients under 35mls - the algorithm states this but shared care does not. P6 of shared care NICE does not recommend denosumab in prostate cancer Remove primary prevention reference and add statement re local agreement around use in men. Approved subject to changes outlined. Page 3 of 5
4 6. Denosumab Shared Care See Item 5 7. Malnutrition and Oral Nutritional Supplements the case for change VB reported that a Task Force has been set up to look at the use of ONS on FP10, in particular procurement of ONS and hospital feeds. Currently hospitals get ONS very cheaply with add-ons such as nurse support and advice lines funded through volumes in primary care prescribing. Options given are: Retain as is model hospitals and HEN/CHANT team to procure, GPs prescribe on FP10 and no additional dietician support to manage malnutrition Dedicated dietician support for primary care dieticians to be integrated into GP practice teams either by FP10 prescribing or non-fp10 managed by dieticians who would have budgetary responsibility. Could be single or multiple supplier based Primary care voucher scheme dieticians would review and recommend food fortification and/or ONS Patients would be issued with vouchers which could be redeemed at supermarkets or pharmacy. JPC recommended Option 1 subject to the following modifications: JPC are keen to commit to better management of malnutrition but would like to approach this as a multidisciplinary, integrated team. JPC would encourage integration into the work of the LAMP project, as part of the Southwark and Lambeth Integrated Care programme and development of a malnutrition pathway as a part of this work. JPC acknowledge that malnutrition could be a more integral part of care pathway commissioning and will raise this internally within our CCGs. JPC would like to work closely with dietician expertise in maximising benefits from ONS, reducing waste and better nutrition, however feel that a procurement solution is not the best way of delivering this at this moment in time ACTION: VB to draft a response to Task Force for Chair s approval. 8. PGD for administration of vaccines by Practice Nurses The revised PGD, which has been developed by Public Health England on behalf of NHS England, was presented to JPC. Rotavirus and shingles have been removed along with some other minor amendments. NICE have recommended a review date of 3 years for PGDs. IJ raised the issue of the new recommendation of nasal spray vaccination for children over 6 years old. The PGD update still refers to vaccination by injection. PSDs will need to be used until PGD is ready. JPC suggested that practices could print a list of the relevant patients which could then be signed by GP. The shingles, rotavirus and nasal spray PGDs are due to be issued very soon by NHS England and a covering letter can be added to this PGD to explain this. The dosage frequency is to be inserted on p36. VB added thanks to Josie Mansell for her work on the update. ACTION: JM to make amendments and circulate for Chair s action 9. Standing Item i. Community Pharmacy Update RP reported some issues with electronic prescribing system and will ask DJ to raise these at LPC. He added that tokens could be printed in the practice when prescriptions fail to arrive at pharmacies. Page 4 of 5
5 10. Items for information i. Minutes of GKLT Joint Formulary Committee (JFC) - noted ii. Minutes of GSTfT Drugs and Therapeutics Committee (DTC) - noted iii. Secondary Care monitoring frameworks (GSTfT) practices should feedback any issues with secondary care prescribing of tadalafil to MMT. iv. NICE Update - noted v. Emollients Guidelines JS summarised the minor amendments and JPC approved the guidelines. To be circulated to practices, community pharmacists, community teams, practice nurses and walk-in centres. 11. AOB None Page 5 of 5
Minutes of the Lambeth and Southwark Joint Prescribing Committee (JPC) meeting pm, Wednesday 15 May 2013 Room GO2-A, 160 Tooley Street
Minutes of the Lambeth and Southwark Joint Prescribing Committee (JPC) meeting 2. 00 pm, Wednesday 15 May 2013 Room GO2-A, 160 Tooley Street Present: Dr Catherine Otty (CO) Dr Alan Campion Dr Sian Howell
More informationSouth East London Area Prescribing Committee (APC) 9 October at Lower Marsh. Final minutes
South East London Area Prescribing Committee (APC) 9 October at Lower Marsh Final minutes 1. Welcome, Introductions and Apologies received. 2. Conflicts of Interest declarations The Chair requested any
More informationSouth East London Interface Prescribing Policy including the NHS and Private Interface Prescribing Guide
South East London Interface Prescribing Policy including the NHS and Private Interface Prescribing Guide 1. Introduction 1.1 This policy has been developed by the South East London Clinical Commissioning
More informationIs Our South East London Area Prescribing Committee Working To Best Practice, Or Could We Be Even Better?
Is Our South East London Area Prescribing Committee Working To Best Practice, Or Could We Be Even Better? Vanessa Burgess, Assistant Director, Medicines & LTCs, NHS Lambeth Clinical Commissioning Group;
More informationPGDs are permitted for use only by registered health professionals (see enclosed link for full list
NHS England North - Yorkshire and the Humber Region Protocol for the Development, Authorisation and Use of Patient Group Directions for the National Immunisation Programmes 1. Introduction The preferred
More information3. Minutes, action log and attendance list of Last Meeting and Matters Arising. The minutes of the March meeting were accepted as accurate.
South East London Area Prescribing Committee (APC) 23 June 2016 at Lower Marsh Approved minutes 1. Welcome, and Introductions 2. Conflicts of Interest declarations The Chair requested any interests, either
More informationNATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE SCOPE
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE 1 Guideline title SCOPE Medicines optimisation: the safe and effective use of medicines to enable the best possible outcomes 1.1 Short title Medicines
More informationPrescribing Policy between Nottinghamshire Commissioning Organisations and local providers of NHS Services
Prescribing Policy between Nottinghamshire Commissioning Organisations and local providers of NHS Services Document Purpose Version 2.2 To detail the specific contractual issues associated with prescribing
More informationReducing medicines waste in Care Settings.
Reducing medicines waste in Care Settings. Good practice Guidance Recommendations for care home staff, prescribers and pharmacists working with care homes. This good practice guidance has been developed
More informationJOB DESCRIPTION. Pharmacy Technician
JOB DESCRIPTION Pharmacy Technician Issued by AT Medics Primary Care Pharmacy Technician Job Description Job Title: Reporting to: Location: Salary: Job status: Contract: Notice Period: Primary care pharmacy
More informationInformation shared between healthcare providers when a patient moves between sectors is often incomplete and not shared in timely enough fashion.
THE DISCHARGE MEDICINES REVIEW SERVICE Introduction During a stay in hospital a patient s medicines may be changed. Studies show that many patients may experience an error or problem with their medicines
More informationNPSA Alert 03: Reducing the harm caused by oral Methotrexate. Implementation Progress Report July Learning and Sharing
NPSA Alert 03: Reducing the harm caused by oral Methotrexate Implementation Progress Report July 2006 Learning and Sharing CONTENTS Page 1 Background 3 2 Findings 4 Appendix 1 Summary of responses 6 Appendix
More informationClinical pharmacists in general practice links with community pharmacy
Introduction Pharmacists employed in the GP clinical pharmacist NHS England programme are encouraged to complete online activity recording. One of the activities records how they are working with community.
More informationMedicines Management Strategy
Medicines Management Strategy 2012 2014 Directorate responsible for the strategy: Medical and Governance Directorate Staff group to whom it applies: All clinical staff and Trust managers Issue date: 30/6/12
More informationSouth East London Area Prescribing Committee (SEL APC) 25 January 2018 at Lower Marsh Final minutes 1. Welcome, and Introductions
South East London Area Prescribing Committee (SEL APC) 25 January 2018 at Lower Marsh Final minutes 1. Welcome, and Introductions 2. Conflicts of Interest declarations The Chair requested any interests,
More informationWORKING WITH THE PHARMACEUTICAL INDUSTRY POLICY Version 1.0
WORKING WITH THE PHARMACEUTICAL INDUSTRY POLICY Version 1.0 1 Standard Operating Procedure St Helens CCG Working with The Pharmaceutical Industry Policy Version 1.0 Implementation Date May 2017 Review
More informationNHS ENGLAND CALL TO ACTION: IMPROVING HEALTH AND PATIENT CARE THROUGH COMMUNITY PHARMACY
Delivering local pharmacy solutions in Sunderland Chair David Carter Secretary Louise Lydon Chair Umesh Patel Secretary Jim Smith NHS ENGLAND CALL TO ACTION: IMPROVING HEALTH AND PATIENT CARE THROUGH COMMUNITY
More informationCCG Policy for Working with the Pharmaceutical Industry
CCG Policy for Working with the Pharmaceutical Industry 1. Introduction Medicines are the most frequently and widely used NHS treatment and account for over 12% of NHS expenditure. The Pharmaceutical Industry
More informationNHS community pharmacy advanced services Briefing for GP practices
NHS community pharmacy advanced services Briefing for GP practices August 2013 This document has been developed jointly by NHS Employers, the Pharmaceutical Services Negotiating Committee (PSNC) and the
More informationMedicines Reconciliation: Standard Operating Procedure
Clinical Medicines Reconciliation: Standard Operating Procedure Document Control Summary Status: Version: Author/Owner/Title: Approved by: Ratified: Related Trust Strategy and/or Strategic Aims Implementation
More informationSPONSORSHIP AND JOINT WORKING WITH THE PHARMACEUTICAL INDUSTRY
SPONSORSHIP AND JOINT WORKING WITH THE PHARMACEUTICAL INDUSTRY 1 SUMMARY This document sets out Haringey Clinical Commissioning Group policy and advice to employees on sponsorship and joint working with
More informationMEDICINES STANDARD B3: WORKING WITH THE PHARMACEUTICAL INDUSTRY
MEDICINES STANDARD B3: WORKING WITH THE PHARMACEUTICAL INDUSTRY NHS employees and contractors link with the pharmaceutical industry in a number of ways, as a source of information, through the receipt
More informationSouth Staffordshire and Shropshire Healthcare NHS Foundation Trust
South Staffordshire and Shropshire Healthcare NHS Foundation Trust Document Version Control Document Type and Title: Authorised Document Folder: Policy for Medicines Reconciliation on Admission and on
More informationNHS and LA Reforms Factsheet 5
NHS and LA Reforms Factsheet 5 Supply of medicines for public health commissioned services a factsheet for local authorities 1. Introduction As of April 2013, local authorities have responsibility for
More informationImplementing bulk prescribing for care home patients
Bulletin 66 May 2014 Community Interest Company Implementing bulk prescribing for care home patients There are many patients in care homes taking medicines when required (prn), and this inevitably presents
More informationVenue: Salford St James House Present: Name Designation Organisation CCG members
GREATER MANCHESTER MEDICINES MANAGEMENT GROUP Minutes Date: Thursday 16 th February 2017 Time: 1pm 3pm Venue: Salford St James House Present: Name Designation Organisation CCG members Dr Helen Burgess
More informationOur pharmacist led care home service
Our pharmacist led care home service Optimising the medicines of patients who are living in a care home. Suppor t Prescribing Ser vices Commissioning a care home medication review service (PSS) is one
More informationGP and Lead Clinician, Respiratory MCN (chair) Respiratory Care Facilitator, WL CHCP
LOTHIAN RESPIRATORY MCN CORE GROUP Minutes of the meeting of Wednesday 18 December 2013 in Seminar Room 6, Chancellor s Building, Royal Infirmary of Edinburgh Present Dr Ninian Hewitt Ms Shena Brown Ms
More informationNHS and Private Interface Prescribing Guide
NHS and Private Interface Prescribing Guide 1 Background 1.1 The following guide has been developed to assist General Practitioners (GPs) in dealing with requests to prescribe by registered patients following
More informationBest Practice Guidelines - BPG 9 Managing Medicines in Care Homes
Best Practice Guidelines - BPG 9 Managing Medicines in Care Homes Medicines in Care Homes 1 DOCUMENT STATUS: Approved DATE ISSUED: 10 th November 2015 DATE TO BE REVIEWED: 10 th November 2017 AMENDMENT
More informationWOLVERHAMPTON CCG. Governing Body Meeting 8 April 2014
WOLVERHAMPTON CCG Governing Body Meeting ` Agenda item:12 TITLE OF REPORT: REPORT PRESENTED BY: Commissioning Committee Summary Dr Kamran Ahmed Title of Report: Update from the Commissioning Committee
More informationNHS BARNSLEY. Minutes of the meeting of the AREA PRESCRIBING COMMITTEE held on Wednesday 13 th February 2013 in the Boardroom at Hillder House.
Minutes of the meeting of the AREA PRESCRIBING COMMITTEE held on Wednesday 13 th February 2013 in the Boardroom at Hillder House. PRESENT: Dr M Ghani (Chair) Medical Director Barnsley CCG (Designate) Dr
More informationNHS Prescription Services CPAF Screening Questionnaire 2017/18
NHS Prescription Services CPAF Screening Questionnaire 207/8 Important Information about this Document This is a reference copy of the Community Pharmacy Assurance Framework Screening Questionnaire, the
More informationFIRST PATIENT SAFETY ALERT FROM NATIONAL PATIENT SAFETY AGENCY (NPSA) Preventing accidental overdose of intravenous potassium
abcdefghijklm Health Department St Andrew s House Regent Road Edinburgh EH1 3DG MESSAGE TO: 1. Medical Directors of NHS Trusts 2. Directors of Public Health 3. Specialists in Pharmaceutical Public Health
More informationJOB DESCRIPTION. 2. To participate in the delivery of medicines administration depending on local need and priorities.
JOB DESCRIPTION JOB TITLE: Clinical Pharmacy Technician PAY BAND: 5 DEPARTMENT/DIVISION: BASED AT: REPORTS TO: PHARMACY/A5 University Hospitals Birmingham Pharmacy Support Manager PROFESSIONALLY RESPONSIBLE
More informationSwitch protocol: Brands to generic equivalent
Switch protocol: Brands to generic equivalent Applies to HaRD CCG employed Pharmacists and Medicines Optimisation Technicians. These protocols are produced by the NY&AWC MM team hosted by HaRD CCG for
More informationNON-MEDICAL PRESCRIBING POLICY
NON-MEDICAL PRESCRIBING POLICY To be read in conjunction with the Medicines Policy, Controlled Drug Policy and the FP10 Prescribing Forms Policy Version: 5 Date of issue: August 2017 Review date: August
More informationCommunity Pharmacy Multi-compartment Compliance Aids Audit
Community Pharmacy Multi-compartment Compliance Aids Audit Introduction To comply with the NHS contractual requirements associated with the Clinical Governance Essential Service, pharmacy contractors must
More informationPRESCRIBING SUPPORT TECHNICIAN:
PRESCRIBING SUPPORT TEAM AUDIT: CARDURA XL (Updated Sept 09) DATE OF AUTHORISATION: AUTHORISING GP: PRESCRIBING SUPPORT TECHNICIAN: SUMMARY Cardura XL is a once daily, extended release preparation of doxazosin
More informationAWMSG RECOMMENDATIONS REGARDING THE PRESCRIBING AND SUPPLY OF SIP FEEDS IN WALES: FOR ADOPTION AND WIDER DISSEMINATION
AWMSG RECOMMENDATIONS REGARDING THE PRESCRIBING AND SUPPLY OF SIP FEEDS IN WALES: FOR ADOPTION AND WIDER DISSEMINATION Background In September 2004, the All Wales Medicines Strategy Group (AWMSG) identified
More informationSELF ADMINISTRATION OF MEDICATIONS PROGRAMME FOR REHABILITATION & RECOVERY SERVICES AND LOW/MEDIUM SECURE SERVICES
MENTAL HEALTH DIRECTORATE POLICY SELF ADMINISTRATION OF MEDICATIONS PROGRAMME FOR REHABILITATION & RECOVERY SERVICES AND LOW/MEDIUM SECURE SERVICES Originator: Mental Health Policies and Procedures Group
More informationNHS PCA (P) (2015) 17 ANNEX B. Specials Frequently Asked Questions for Community Pharmacy. Pre-authorisation:
ANNEX B Specials Frequently Asked Questions for Community Pharmacy Pre-authorisation: Q: When do I need to seek authorisation? A: You need to seek authorisation for all Specials manufactured medicines
More informationNHS Lanarkshire Policy for the Availability of Unlicensed Medicines
NHS Lanarkshire Policy for the Availability of Unlicensed Medicines Prepared by: NHS Lanarkshire Chief Pharmacist Endorsed by: Area Drug & Therapeutic Committee Previous Version/Date: Primary Policy Date:
More informationManaging medicines in care homes
Managing medicines in care homes http://www.nice.org.uk/guidance/sc/sc1.jsp Published: 14 March 2014 Contents What is this guideline about and who is it for?... 5 Purpose of this guideline... 5 Audience
More informationProcess and methods Published: 23 January 2017 nice.org.uk/process/pmg31
Evidence summaries: process guide Process and methods Published: 23 January 2017 nice.org.uk/process/pmg31 NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).
More informationNHS Prescription Services CPAF Screening Questionnaire 2018/19
NHS Prescription Services CPAF Screening Questionnaire 08/9 Important Information about this Document This is a reference copy of the Community Pharmacy Assurance Framework Screening Questionnaire, the
More informationSouth East London Area Prescribing Committee (APC) 13 October 2016 at Lower Marsh Approved minutes 1. Welcome, and Introductions
South East London Area Prescribing Committee (APC) 13 October 2016 at Lower Marsh Approved minutes 1. Welcome, and Introductions 2. Conflicts of Interest declarations The Chair requested any interests,
More informationNorth School of Pharmacy and Medicines Optimisation Strategic Plan
North School of Pharmacy and Medicines Optimisation Strategic Plan 2018-2021 Published 9 February 2018 Professor Christopher Cutts Pharmacy Dean christopher.cutts@hee.nhs.uk HEE North School of Pharmacy
More informationMedicines Management Policy
Medicines Management Policy Name of Policy: Purpose of Policy: Directorate responsible for Policy Name & Title of Author: Medicines Management Policy The Southern HSC Trust recognises that almost all patients
More informationPOLICY FOR ANTICIPATORY PRESCRIBING FOR PATIENTS WITH A TERMINAL ILLNESS Just in Case
POLICY FOR ANTICIPATORY PRESCRIBING FOR PATIENTS WITH A TERMINAL ILLNESS Just in Case DOCUMENT NO: DN116 Lead author/initiator(s): Sarah Woodley Community Health Services Pharmacist sarah.woodley@ccs.nhs.uk
More informationDate of publication:june Date of inspection visit:18 March 2014
Jubilee House Quality Report Medina Road, Portsmouth PO63NH Tel: 02392324034 Date of publication:june 2014 www.solent.nhs.uk Date of inspection visit:18 March 2014 This report describes our judgement of
More informationAppendix E: Pharmacy contractor questionnaire
Appendix E: Pharmacy or questionnaire Lincolnshire Health and Wellbeing Board PNA Pharmacy Questionnaire Soar Beyond are supporting Lincolnshire County Council to produce their 2018 Pharmaceutical Needs
More informationHospital Pharmacy Transformation Plan
Hospital Pharmacy Transformation Plan Introduction In June 2014, Lord Carter of Coles was appointed to the position of Chair of a new NHS Procurement & Efficiency Board to direct the NHS Procurement &
More informationCLINICAL PROTOCOL FOR THE DEVELOPMENT AND IMPLEMENTATION OF PATIENT GROUP DIRECTIONS (PGD)
CLINICAL PROTOCOL FOR THE DEVELOPMENT AND IMPLEMENTATION OF PATIENT GROUP DIRECTIONS (PGD) DEFINITION A Patient Group Direction (PGD) is a specific written instruction for the supply and administration
More informationNHS PCA (P) (2015) 17. Dear Colleague
Healthcare Quality and Strategy Directorate Pharmacy and Medicines Division Dear Colleague PHARMACEUTICAL SERVICES AMENDMENTS TO DRUG TARIFF IN RESPECT OF SPECIAL PREPARATIONS AND IMPORTED UNLICENSED MEDICINES
More informationSection Title. Prescribing competency framework Catherine Picton, Lead author
Prescribing competency framework Catherine Picton, Lead author What is in this presentation Context Uses of the competency framework Scope of the updated prescribing competency framework Introduction to
More informationVale of York Clinical Commissioning Group Governing Body Public Health Services. 2 February Summary
Vale of York Clinical Commissioning Group Governing Body Public Health Services 2 February 2017 Summary 1. The purpose of this report is to provide the Vale of York Clinical Commissioning Group (CCG) with
More informationGOOD PRACTICE GUIDELINES Patient safety and reducing waste
POLICY DOCUMENT GOOD PRACTICE GUIDELINES Patient safety and reducing waste Authors: Consultation at: Approved by: Shazia Patel, Senior Prescribing Advisor Anju Mistry: Senior Pharmacist Phyllis Navti Head
More informationBest Practice Guidance for Supplementary Prescribing by Nurses Within the HPSS in Northern Ireland. patient CMP
Best Practice Guidance for Supplementary Prescribing by Nurses Within the HPSS in Northern Ireland patient CMP nurse doctor For further information relating to Nurse Prescribing please contact the Nurse
More informationStandards for the provision and use of Medicines Administration Record (MAR) charts
Standards for the provision and use of Medicines Administration Record (MAR) charts Background The MAR chart is the formal record of administration of medicines and may be required to be used as evidence
More informationNon Medical Prescribing Policy
Non Medical Prescribing Policy Author: Sponsor/Executive: Responsible committee: Ratified by: Consultation & Approval: (Committee/Groups which signed off the policy, including date) This document replaces:
More informationDocument Details. notification of entry onto webpage
Document Details Title Patient Group Direction (PGD) Administration of sodium chloride 0.9% injection by registered professionals Trust Ref No 1987-38096 Local Ref (optional) Main points the document As
More informationReport to Governing Body 19 September 2018
Report to Governing Body 19 September 2018 Report Title Author(s) Governing Body/Clinical Lead(s) Management Lead(s) CCG Programme Purpose of Report Summary NHS Lambeth Clinical Commissioning Group (CCG)
More informationSource Question Summary response Action Proposal to set up a review of community services:
NHS Lambeth CCG Public forum 1 st March 2017 tes Source Question Summary response Action Proposal to set up a review of community services: In light of the Primary Care Trusts transfer to CCGs in 2013
More informationCommunity Pharmacy in 2016/17 and beyond
Community Pharmacy in 2016/17 and beyond Stakeholder briefing sessions 1 CONTENTS Contents This presentation describes our vision for community pharmacy, and outlines proposals for achieving that vision,
More informationIntegrated respiratory action network for patients with COPD
Integrated respiratory action network for patients with COPD In this Future Hospital Programme case study Dr Helen Ward describes how a team from The Royal Wolverhampton NHS Trust established a respiratory
More informationGuidance on the Delivery of Medicines Dispensed on Foot of a Prescription from a Retail Pharmacy Business
Guidance on the Delivery of Medicines Dispensed on Foot of a Prescription from a Retail Pharmacy Business Pharmaceutical Society of Ireland Version 1 July 2014 Contents 1. Introduction 2 2. Guidance 3
More informationGuidance on the prescribing of medication initiated or recommended either after a private episode of care or a referral to a tertiary NHS centre
Guidance on the prescribing of medication initiated or recommended either after a private episode of care or a referral to a tertiary NHS centre GUIDELINE VERSION 2 RATIFYING COMMITTEE Drugs and Therapeutics
More informationPharmacy Medicine Use Review What s it all about?
Pharmacy Medicine Use Review What s it all about? 1. What is it? 1.1 Medicine use Review has been introduced under the Advanced Services tier of the New Pharmacy Contract in England & Wales. The aim of
More informationAnti-Coagulation Monitoring (warfarin, acenocoumarol, phenindione) Primary Care Service (PCS:01) NHS Standard Contract Service Profile Pack ( )
Anti-Coagulation Monitoring (warfarin, acenocoumarol, phenindione) Primary Care Service (PCS:01) This pack contains: Standard Contract Service Profile Pack () 1. Service Specification: (to be inserted
More informationMedicines Management Guidance
Medicines Management Guidance Status Final Version 1.0 Author Jon Boyd Version date 05/12/2016 Agreed by the following North West London CCGs: Central London West London Hammersmith and Fulham Hounslow
More informationImproving compliance with oral methotrexate guidelines. Action for the NHS
Patient safety alert 13 Alert Immediate action Action Update Information request Ref: NPSA/2006/13 Improving compliance with oral methotrexate guidelines Oral methotrexate is a safe and effective medication
More informationPrimary Care Co Commissioning Committee Minutes of Meeting held in Public on Wednesday 22 nd June
Primary Care Co Commissioning Committee Minutes of Meeting held in Public on Wednesday 22 nd June 2016 14.00-16.00 Boardroom, SRCCG Offices, Town Hall, Scarborough Chair: Andy Hudson Present Greg Black
More informationLincolnshire County Council Officers: Professor Derek Ward (Director of Public Health) and Sally Savage (Chief Commissioning Officer)
Agenda Item 5 1 LINCOLNSHIRE HEALTH AND WELLBEING BOARD PRESENT: COUNCILLOR MRS S WOOLLEY (CHAIRMAN) Lincolnshire County Council: Councillors C N Worth (Executive Councillor Culture and Emergency Services),
More informationSocial care guideline Published: 14 March 2014 nice.org.uk/guidance/sc1
Managing medicines in care homes Social care guideline Published: 14 March 2014 nice.org.uk/guidance/sc1 NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).
More informationThe Value of Working in Partnership with Care Homes to Provide a Unique and Sustainable Approach to Malnutrition
The Value of Working in Partnership with Care Homes to Provide a Unique and Sustainable Approach to Malnutrition A presentation delivered by: Vittoria Romano, Registered Dietitian & Catherine Blanchard,
More informationMEDICINES RECONCILIATION GUIDELINE Document Reference
MEDICINES RECONCILIATION GUIDELINE Document Reference G358 Version Number 1.01 Author/Lead Job Title Jackie Stark Principle Pharmacist Clinical Services Date last reviewed, (this version) 29 November 2012
More informationTo contact us please
Issue 13, June 2015 Newsletter for Care Home staff, General Practitioners and Community Pharmacists The Caring for Care Homes team produced The Medicines Management Checklist in 2010 to provide care homes
More informationOne months notice of termination must be given if the pharmacy wishes to terminate the agreement before the given end date.
Service Level Agreement for a Local Service for the Provision of Domiciliary Medicine Use Reviews Please note that for this service will be commissioned for a limited number of patients initially 10 (TEN)
More informationCouncil of Members. 20 January 2016
Council of Members 20 January 2016 Feedback on election process: Council of Members Chair and Deputy Chair Malcolm Hines, Chief Financial Officer Minutes of last meeting: 14 October 2015 Dr. Richard Proctor,
More informationMINUTES OF THE MEDICINES MANAGEMENT GROUP MEETING
MINUTES OF THE MEDICINES MANAGEMENT GROUP MEETING Date & Time of Meeting: Venue: Wednesday 8 th February 2012 @ 1.30pm Boardroom, Glangwili Hospital, Carmarthen Present: In Attendance: Dr. Carol Llewellyn-Jones,
More informationWith these corrections made, it was agreed that the Minutes be approved as a correct record.
Agenda item 14 CCG Operational Leadership Team 18 July 2013, 8.30 11.30am Board Room, Trust HQ, St Martin s Hospital In Attendance: Simon Douglass (Chair) (SD) Hester McLain (For Item 10) Tracey Cox (Chair)
More informationCompetencies and Training Framework
Community Pharmacy Enhanced Services Competencies and Training Framework Enhanced Service: Provision of Minor Ailments Service Level 1 (P & GSL medicines only) Level 2 (POMs, P & GSL) Version: Version
More informationMinutes 18 July 3.00pm 4.30pm Surrey Heath House, Knoll Road, Camberley, Surrey GU15 3HD Michele Harrison, Quality Manager
Quality and Clinical Governance Committee Date Chair Minutes 18 July @ 3.00pm 4.30pm Surrey Heath House, Knoll Road, Camberley, Surrey GU15 3HD Michele Harrison, Quality Manager Members Present Gareth
More informationPatients Own Medications Policy
Department of Health and Human Services SYSTEM PURCHASING AND PERFORMANCE - MEDICATION STRATEGY AND REFORM SDMS Id Number: Patients Own Medications Policy Effective From: June 2014 Replaces Doc. No: Custodian
More informationSTRATEGIES TO ACHIEVE COST-EFFECTIVE PRESCRIBING
STRATEGIES TO ACHIEVE COST-EFFECTIVE PRESCRIBING Interim Guidance for Primary Care Trusts STRATEGIES TO ACHIEVE COST- EFFECTIVE PRESCRIBING: Interim Guidance for Primary Care Trusts Prepared by Colin Pearson
More informationPrescribing Advisor for BHR CCGs, representing Barking & Dagenham (B&D) CCG Prescribing Advisor for BHR CCGs, representing Redbridge CCG
BHR CCGs AREA PRESCRIBING SUB-COMMITTEES Thursday 5 th November 2015 BOARDROOM A, BECKETTS HOUSE, ILFORD, IG1 2QX PRESENT Dr G Kalkat (GK) Oge Chesa (OC) Belinda Krishek (BK) Dr C Okorie (CO) Dr K Kugathas
More informationANTI-COAGULATION MONITORING
ANTI-COAGULATION MONITORING 2016-17 a) Purpose of Agreement This Agreement outlines the service to be provided by the Provider, called an Anti-coagulation monitoring service. b) Duration of Agreement This
More informationAppendix 2. Community Pharmacy Emergency Hormonal Contraception Service
Appendix 2 Community Pharmacy Emergency Hormonal Contraception Service 2014 until end November 2016 Contents Executive Summary... 3 Aims and intended service outcomes of the service... 3 Brief service
More informationLonger, healthier lives for all the people in Croydon
D R A F T Croydon Clinical Commissioning Group Prospectus 2013/14 Longer, healthier lives for all the people in Croydon (Version TL) 1 Contents Foreword from the chair 3 Introduction 4 Who we are our Governing
More informationQ. How does the GP practice get their clinical system set up for Repeat Dispensing?
Repeat Dispensing Questions and Answers Since the introduction of Repeat Dispensing in Northern Ireland in May 2005, both community pharmacists and GP practices have frequently asked the same questions
More informationImportant message to all GPs in England on changes to the GP contract for 2018/19, from Dr Richard Vautrey GPC England Chair
Important message to all GPs in England on changes to the GP contract for 2018/19, from Dr Richard Vautrey GPC England Chair Dear Colleague, The BMA GPs committee (GPC) England has concluded negotiations
More informationAll areas of the Trust All Trust staff All Patients Deputy Chief Nurse & Chief Pharmacist Final
Trust Policy and Procedure Document Ref. No: PP(15)233 Non-Medical Prescribing Policy For use in: For use by: For use for: Document owner: Status: All areas of the Trust All Trust staff All Patients Deputy
More informationNHS Innovation Accelerator. Implementation Toolkit. mycopd
NHS Innovation Accelerator Implementation Toolkit mycopd Introduction NHS England s Innovation and Technology Tariff (ITT) went live on 1 April 2017. This new Tariff was introduced to incentivise the adoption
More informationPharmacy, Medicines and You. Principal Pharmacist Pharmaceutical Services Deputy Director of Pharmacy and Medicines Management
Pharmacy, Medicines and You Wendy Robertson Liz Kemp Caroline Hind Principal Pharmacist Pharmaceutical Services Principal Pharmacist Pharmaceutical Services Deputy Director of Pharmacy and Medicines Management
More informationA Carers Guide to Managing Medicines
A Carers Guide to Managing Medicines Contents When to give medicines 3 How to give medicines 3 Ordering repeat prescriptions 3 Collecting medicines 3 Buying medicines 3 Safe storage 4 Disposing of medicines
More informationNorth Central London Medicines Optimisation Network. Terms of Reference. North Central London Medicines Optimisation Network 1 of 8
North Central London Medicines Optimisation Network Medicines Optimisation Committee Terms of Reference North Central London Medicines Optimisation Network 1 of 8 Document control Date Version Amendments
More informationPHARMACIST INDEPENDENT PRESCRIBING MEDICAL PRACTITIONER S HANDBOOK
PHARMACIST INDEPENDENT PRESCRIBING MEDICAL PRACTITIONER S HANDBOOK 0 CONTENTS Course Description Period of Learning in Practice Summary of Competencies Guide to Assessing Competencies Page 2 3 10 14 Course
More informationCoventry and Warwickshire PNA
Premises Details Contractor Code (ODS Code) Coventry and Warwickshire PNA Community Pharmacy Survey Name of contractor (i.e. name of individual, partnership or company owning the pharmacy business) If
More informationDear Colleague. November 2013
NHS Circular: PCA (P) (2013) 29 ehealth, Finance & Pharmaceutical Directorate Pharmacy & Medicines Division Dear Colleague ADDITIONAL PHARMACEUTICAL SERVICES INTRODUCTION OF GLUTEN FREE FOOD SERVICE TIMETABLE,
More information